Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and Steroid Combination for Keloid Recurrence
NCT06965088Phase 2Active, not recruiting
- Sponsor
- Ramathibodi Hospital
- Start
- Apr 2025
- Primary completion
- Jun 2026
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
A Phase 2 trial of platelet-rich plasma in keloid, sponsored by Ramathibodi Hospital. Started Apr 2025; status: active, not recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
keloid
Beyond the preview
Go deeper on NCT06965088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06965088.